3D Dose Delivery Verification for Stereotactic Body Radiotherapy of Non-Small Cell Lung Cancer

Strategic Insights -

Scientists in the Netherlands have conducted a study to implement a 3D dose verification procedure for lung cancer patients treated with stereotactic body radiotherapy (SBRT). The method uses in-room cone-beam CT imaging and portal dosimetry to ensure accurate dose delivery. The researchers found that the procedure is independent of the treatment planning system and allows for verification of the delivered dose in 3D.

Key Takeaways:

  • The study aimed to implement a 3D dose verification procedure for SBRT of non-small cell lung cancer patients using in-room cone-beam CT imaging and portal dosimetry.
  • The method involves capturing treatment fields using a calibrated electronic portal imaging device (EPID) and a Monte Carlo dose reconstruction model to estimate the 3D dose delivered to the patient.
  • The planned and delivered dose distributions were compared for 4 patients and 10 treatment fractions using dose-volume histograms and gamma analysis.
  • The gamma analysis showed a good agreement between the planned and delivered dose distributions for patients without changes in anatomy.
  • The delivered mean dose per fraction inside the target volume deviated on average 1.1% from the planned dose.
  • van and colleagues presented a method that allows verification of the dose delivered in 3D for lung cancer patients treated with SBRT.
  • The procedure is independent of the treatment planning system and uses in-room MV cone-beam CT imaging and portal dosimetry.
  • The study was conducted at Maastricht University, Department of Radiation Oncology, under the supervision of W. van Elmpt.
  • The researchers concluded that the procedure is a valuable tool for ensuring accurate dose delivery in SBRT.

Statistics:

  • 4 patients were included in the study to assess the 3D dose verification procedure.
  • 10 treatment fractions were analyzed using dose-volume histograms and gamma analysis.
  • The delivered mean dose per fraction inside the target volume deviated on average 1.1% from the planned dose.
  • The procedure was found to be independent of the treatment planning system.
  • The study was published in Radiotherapy and Oncology (Volume 94, Issue 2, 2010).

Sources:

  • Elmpt W. van et al., Maastricht University, Department of Radiation Oncology, (2010) 3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cell lung cancer. Radiotherapy and Oncology, Volume 94, Issue 2, pp. 188-94.
  • Cancer Weekly editors, (2010) "3D Dose Delivery Verification for Stereotactic Body Radiotherapy of Non-Small Cell Lung Cancer," Cancer Weekly via NewsRx.com.